Should You Accumulate NGM Biopharmaceuticals Inc (NGM) in Biotechnology Industry?

Wednesday, October 13, 2021 01:01 PM | InvestorsObserver Analysts

Mentioned in this article

Should You Accumulate NGM Biopharmaceuticals Inc (NGM) in Biotechnology Industry?

NGM Biopharmaceuticals Inc (NGM) is around the top of the Biotechnology industry according to InvestorsObserver. NGM received an overall rating of 50, which means that it scores higher than 50 percent of all stocks. NGM Biopharmaceuticals Inc also achieved a score of 74 in the Biotechnology industry, putting it above 74 percent of Biotechnology stocks. Biotechnology is ranked 83 out of the 148 industries.

NGM has an Overall Score of 50. Find out what this means to you and get the rest of the rankings on NGM!

See Full NGM Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 50 would rank higher than 50 percent of all stocks. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With NGM Biopharmaceuticals Inc Stock Today?

NGM Biopharmaceuticals Inc (NGM) stock has fallen -1.12% while the S&P 500 is higher by 0.07% as of 1:00 PM on Wednesday, Oct 13. NGM has fallen -$0.23 from the previous closing price of $20.49 on volume of 328,716 shares. Over the past year the S&P 500 has gained 23.97% while NGM is higher by 18.69%. NGM lost -$1.67 per share the over the last 12 months. Click Here to get the full Stock Report for NGM Biopharmaceuticals Inc stock.